[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Glucose metabolism is normally regulated by a feedback loop including islet β cells and
insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell …
insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell …
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview
DM Nathan, DCCT/Edic Research Group - Diabetes care, 2014 - Am Diabetes Assoc
OBJECTIVE The Diabetes Control and Complications Trial (DCCT) was designed to test the
glucose hypothesis and determine whether the complications of type 1 diabetes (T1DM) …
glucose hypothesis and determine whether the complications of type 1 diabetes (T1DM) …
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology …
NJ Stone, JG Robinson, AH Lichtenstein… - Circulation, 2014 - Am Heart Assoc
The Blood Cholesterol Expert Panel (Expert Panel) was originally convened as the Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult …
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult …
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and …
Authors/Task Force Members, L Rydén… - European heart …, 2013 - academic.oup.com
ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …
the two organizations. It is our hope that this huge effort has generated guidelines that will …
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association
SD De Ferranti, IH De Boer, V Fonseca, CS Fox… - Circulation, 2014 - Am Heart Assoc
(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …
Molecular mechanisms of diabetic kidney disease
K Reidy, HM Kang, T Hostetter… - The Journal of clinical …, 2014 - Am Soc Clin Investig
Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide and the
single strongest predictor of mortality in patients with diabetes. DKD is a prototypical disease …
single strongest predictor of mortality in patients with diabetes. DKD is a prototypical disease …
Heart disease and stroke statistics—2013 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin… - Circulation, 2013 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …
for Disease Control and Prevention, the National Institutes of Health, and other government …
Mechanisms of diabetic complications
It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic
required, but also for its major complications, affecting both small and large blood vessels …
required, but also for its major complications, affecting both small and large blood vessels …
Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis
OBJECTIVE Glycemic variability is emerging as a measure of glycemic control, which may
be a reliable predictor of complications. This systematic review and meta-analysis evaluates …
be a reliable predictor of complications. This systematic review and meta-analysis evaluates …